Farallon Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Farallon Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-520,021	Closed	-$2.49M	–	342
2021 Q4	$2.49M	Sell	520,021 -479,979	-48%	-$3.1M	0.01%	206
2021 Q3	$7.57M	Hold	1,000,000	–	–	0.04%	149
2021 Q2	$7.46M	Hold	1,000,000	–	–	0.03%	152
2021 Q1	$7.8M	Hold	1,000,000	–	–	0.04%	155
2020 Q4	$9.24M	Buy	+1,000,000	New	+$8.69M	0.06%	110
2018 Q3	–	Sell	-100,000	Closed	-$1.63M	–	114
2018 Q2	$1.63M	Buy	+100,000	New	+$1.45M	0.01%	93

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management's SURF Position: Q1 2022 in Review

Farallon Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 520,021 shares — an estimated $2.49M sold.

Farallon Capital Management first reported a position in SURF in Q2 2018 and held it in 6 quarters. The position peaked at $9.24M in Q4 2020. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

Farallon Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Farallon Capital Management sold 520,021 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $2.49M.
Farallon Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Farallon Capital Management's Surface Oncology, Inc. Common Stock position peaked at $9.24M in Q4 2020.
103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.